Using Lamin B1 MRNA for the Early Diagnosis of Hepatocellular Carcinoma: a Cross-sectional Diagnostic Accuracy Study

Overview

Journal F1000Res

Specialties Biomedical Engineering
Science

Date 2018 Nov 24

PMID 30467522

Citations 5

Authors

Amani M Abdelghany

Nasser Sadek Rezk

Mona Mostafa Osman

Amira I Hamid

Ashraf Mohammad Al-Breedy

Hoda A Abdelsattar

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is vital medical issue in Egypt. It accounts for 70.48% of all liver tumors among Egyptians. The aim of this study was to determine the diagnostic role of plasma levels of mRNA of lamin B1 by RT-qPCR as an early marker of HCC. This study was conducted at the Clinical Pathology Department in collaboration with the Department of Tropical Medicine and Infectious Diseases at Ain Shams University Hospitals. It included 30 patients with primary HCC and viral cirrhosis (all were hepatitis C virus-positive) (Group I), in addition to 10 patients with chronic liver diseases (Group II) and 10 healthy age- and sex-matched subjects (Group III). Group I was further classified according to the Barcelona-Clinic Liver Cancer Staging System. Serum α-fetoprotein (AFP) chemiluminescent-immunoassays and RT-qPCR analysis of plasma lamin B1 mRNA levels were performed for all participants. AFP and lamin B1 significantly elevated in patients with HCC compared to those in the other studied groups. AFP and lamin B1 status could discriminate group I from group II and III. A significant increase was found among the three Barcelona stages with regards to AFP and lamin B1 levels. A significant decrease was found between group II and stage 0, A and B with regards to AFP and lamin B1. Lamin B1 and AFP could both differentiate HCC patients with one tumor nodule (T1) from those with two or more tumor nodules (T2&Tm), as well as between those with tumor sizes >3 cm and ≤3 cm. Measurement of lamin B1 mRNA is recommended in patients with chronic liver disease with normal serum AFP, especially in known cirrhotic patients that deteriorate rapidly without any apparent etiology.

Citing Articles

Mechanism and role of nuclear laminin B1 in cell senescence and malignant tumors.

Lv T, Wang C, Zhou J, Feng X, Zhang L, Fan Z Cell Death Discov. 2024; 10(1):269.

PMID: 38824174 PMC: 11144256. DOI: 10.1038/s41420-024-02045-9.

Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma.

Chun K Pharmaceutics. 2022; 14(7).

PMID: 35890276 PMC: 9316959. DOI: 10.3390/pharmaceutics14071380.

Scaling concepts in 'omics: Nuclear lamin-B scales with tumor growth and often predicts poor prognosis, unlike fibrosis.

Vashisth M, Cho S, Irianto J, Xia Y, Wang M, Hayes B Proc Natl Acad Sci U S A. 2021; 118(48).

PMID: 34810266 PMC: 8640833. DOI: 10.1073/pnas.2112940118.

Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Colli A, Nadarevic T, Miletic D, Giljaca V, Fraquelli M, Stimac D Cochrane Database Syst Rev. 2021; 4:CD013346.

PMID: 33855699 PMC: 8078581. DOI: 10.1002/14651858.CD013346.pub2.

Using Lamin B1 mRNA for the early diagnosis of hepatocellular carcinoma: a cross-sectional diagnostic accuracy study.

Abdelghany A, Rezk N, Osman M, Hamid A, Al-Breedy A, Abdelsattar H F1000Res. 2018; 7:1339.

PMID: 30467522 PMC: 6208568. DOI: 10.12688/f1000research.14795.1.

References

Kim M, Bae K, Seo P, Jeong I, Kim J, Lee B . [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve]. Korean J Hepatol. 2006; 12(3):404-11. View

Solovei I, Wang A, Thanisch K, Schmidt C, Krebs S, Zwerger M . LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell. 2013; 152(3):584-98. DOI: 10.1016/j.cell.2013.01.009. View

Liu H, Zhang J, Wang S, Pang Z, Wang Z, Zhou W . Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system. Cancer Epidemiol. 2011; 36(1):82-8. DOI: 10.1016/j.canep.2011.04.001. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. DOI: 10.3322/caac.21254. View

Furihata T, Sawada T, Kita J, Iso Y, Kato M, Rokkaku K . Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy. Hepatogastroenterology. 2008; 55(86-87):1705-9. View

Broers J, Ramaekers F, Bonne G, Ben Yaou R, Hutchison C . Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev. 2006; 86(3):967-1008. DOI: 10.1152/physrev.00047.2005. View

Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C . Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?. Am J Gastroenterol. 2006; 101(3):524-32. DOI: 10.1111/j.1572-0241.2006.00443.x. View

Wong K, Luk J . Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma. Methods Mol Biol. 2012; 909:295-310. DOI: 10.1007/978-1-61779-959-4_19. View

Sun S, Xu M, Poon R, Day P, Luk J . Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J Proteome Res. 2009; 9(1):70-8. DOI: 10.1021/pr9002118. View

10.

Lim S, Park S, Kim W, Park S, Kim H, Kim Y . Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun. 2002; 291(4):1031-7. DOI: 10.1006/bbrc.2002.6547. View

11.

Pugh R, Murray-Lyon I, Dawson J, Pietroni M, Williams R . Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8):646-9. DOI: 10.1002/bjs.1800600817. View

12.

Page R, Stromberg A . Linear methods for analysis and quality control of relative expression ratios from quantitative real-time polymerase chain reaction experiments. ScientificWorldJournal. 2011; 11:1383-93. PMC: 5548287. DOI: 10.1100/tsw.2011.124. View

13.

Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3):1020-2. PMC: 3084991. DOI: 10.1002/hep.24199. View

14.

Zhao C, Nguyen M . Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice. J Clin Gastroenterol. 2015; 50(2):120-33. DOI: 10.1097/MCG.0000000000000446. View

15.

Abdelghany A, Rezk N, Osman M, Hamid A, Al-Breedy A, Abdelsattar H . Using Lamin B1 mRNA for the early diagnosis of hepatocellular carcinoma: a cross-sectional diagnostic accuracy study. F1000Res. 2018; 7:1339. PMC: 6208568. DOI: 10.12688/f1000research.14795.1. View

16.

Bosetti C, Turati F, La Vecchia C . Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol. 2014; 28(5):753-70. DOI: 10.1016/j.bpg.2014.08.007. View

17.

Yang G, Fan J, Xu Y, Qiu S, Yang X, Shi G . Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist. 2008; 13(11):1155-65. DOI: 10.1634/theoncologist.2008-0081. View

18.

Yang S, Chang S, Yin L, Tu Y, Hu Y, Yoshinaga Y . An absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair. Hum Mol Genet. 2011; 20(18):3537-44. PMC: 3159554. DOI: 10.1093/hmg/ddr266. View

19.

Ziada D, El Sadany S, Soliman H, Abd-Elsalam S, Salama M, Hawash N . Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study. J Egypt Natl Canc Inst. 2016; 28(4):257-262. DOI: 10.1016/j.jnci.2016.06.001. View

20.

Manini M, Sangiovanni A, Fornari F, Piscaglia F, Biolato M, Fanigliulo L . Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. J Hepatol. 2014; 60(5):995-1001. DOI: 10.1016/j.jhep.2014.01.006. View